Evidence map›Paper›PMID 39438661›Full record

ArticleLab animal2024

A novel model of cardiovascular-kidney-metabolic syndrome combining unilateral nephrectomy and high-salt-sugar-fat diet in mice.

Lucas Rannier R A Carvalho, Miho Shimari, Ariela Maína Boeder, Zhengbing Zhuge, Min Cai, Cecilia Leijding, Stefano Gastaldello, Andrei L Kleschyov, Tomas A Schiffer, Drielle Dantas Guimarães and 9 more

Abstract read
In one paragraph

Article in Lab animal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A novel mouse model of adenine-supplemented high-fat diet induced cardiovascular-kidney-metabolic syndrome.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Lucas Rannier R A CarvalhoDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5875-8573
Miho ShimariDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Ariela Maína BoederDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Zhengbing ZhugeDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Min CaiDivision of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Cecilia LeijdingDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Stefano GastaldelloDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Andrei L KleschyovDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Tomas A SchifferDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Drielle Dantas GuimarãesDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Gaia PicozziDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Lars H LundDepartment of Medicine, Cardiology Unit, Karolinska Institutet, Stockholm, Sweden.
Bengt FellströmDepartment of Medical Science, Renal Unit, University Hospital, Uppsala, Sweden.
Eddie WeitzbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Jon O LundbergDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Carolina E HagbergDivision of Cardiovascular Medicine, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-5497-2855
Gianluigi PirontiDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Daniel C AnderssonDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4548-702X
Mattias CarlströmDepartment of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. mattias.carlstrom@ki.se.ORCID 0000-0001-9923-8729

Funding

Hjärt-Lungfonden (Swedish Heart-Lung Foundation) 20210431 and 20170124Karolinska Institutet (Karolinska Institute) 2022-01146 (Gösta Fraenckel)Novo Nordisk Fonden (Novo Nordisk Foundation) 2019#0055026Vetenskapsrådet (Swedish Research Council) 2020-01645
6 · The paper itself

Abstract

The aim of this study was to explore biological interaction and pathophysiology mechanisms in a new mouse model of cardiovascular-kidney-metabolic (CKM) syndrome, induced by chronic moderate renal failure in combination with consumption of a customized Western diet rich in carbohydrates, fat and salt. Male C57BL/6J mice were subjected to unilateral nephrectomy, fed a customized Western diet rich not only in sugar and fat but also in salt, and followed for 12 weeks or 20 weeks. Sham-operated mice on a standard chow served as healthy controls. Body composition, weight gain, glucose metabolism, fat distribution, blood pressure, cardiac function, vascular reactivity, renal function, inflammation and mitochondrial function were measured and combined with biochemical and histopathological analyses. The novel triple-hit model of CKM syndrome showed signs and symptoms of metabolic syndrome, disturbed glucose metabolism, impaired adipocyte physiology and fat redistribution, cardiovascular dysfunction, renal damage and dysfunction, systemic inflammation, elevated blood pressure and cardiac remodeling. The pathological changes were more pronounced in mice after prolonged exposure for 20 weeks, but no deaths occurred. In the present mouse model of CKM syndrome, profound and significant metabolic, cardiac, vascular and renal dysfunctions and injuries emerged by using a Western diet rich not only in fat and carbohydrates but also in salt. This multisystem disease model could be used for mechanistic studies and the evaluation of new therapeutic strategies.

Indexed as

Diet, High-FatDisease Models, AnimalMetabolic SyndromeMice, Inbred C57BLNephrectomyAnimalsCardio-Renal SyndromeDietary SugarsDiet, WesternKidneyMaleMiceSodium Chloride, DietaryDietary SugarsSodium Chloride, Dietary

Identifiers

PMID39438661
PMCPMC11519006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.